Fellowship of CONICET, Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, 60 y 120, 1900, La Plata, Argentina.
Naunyn Schmiedebergs Arch Pharmacol. 2011 Jun;383(6):563-71. doi: 10.1007/s00210-011-0632-z. Epub 2011 Apr 12.
The objective of this study is to assess the participation of mitochondrial ATP-sensitive potassium (mitoK(ATP)) channels in the cardioprotective effects of the Na(+)/H(+) exchanger (NHE-1) blocker cariporide in isolated rat hearts. Regional ischemia was induced by occlusion of left anterior descending coronary artery during 40 min followed by 2-h reperfusion (IC). Cariporide (C, 10 μΜ), or C plus 5-hydroxydecanoate (5-HD, 100 μM, a selective mitoK(ATP) channel inhibitor), or C plus chelerythrine (Chele, 1 μM, a PKC inhibitor), or an opener of mitoK(ATP) channels, diazoxide (Dz, 100 μM) was applied at the onset of reperfusion. Infarct size (IS) and myocardial function were evaluated. The calcium-induced permeability transition pore (mPTP) opening was determined by measuring the light scattering decrease (LSD, a.u.) in isolated mitochondria in the absence and presence of C, C + 5-HD and Dz. IS was 33 ± 2% of the risk area in IC and was significantly diminished by C (15 ± 2%, p < 0.05), which also improved myocardial function [LVDP = 58 ± 5% (IC) vs 80 ± 5% (C)] and blunted LSD [0.80 ± 0.04 (IC) vs 0.51 ± 0.04 (C) a.u.]. 5-HD and Chele were both able to abolish the cardioprotective effects of C on IS. Dz treatment decreased IS and LSD to a similar extent to that produced by C (15 ± 4% and 0.52 ± 0.04 a.u., respectively). The present data suggest that attenuation of mPTP opening after PKC-mediated mitoK(ATP) channel activation is a crucial step for the cardioprotective effects of cariporide.
本研究旨在评估线粒体三磷酸腺苷敏感钾 (mitoK(ATP)) 通道在 Na(+)/H(+) 交换体 (NHE-1) 阻滞剂 cariporide 对分离大鼠心脏的心脏保护作用中的作用。左前降支冠状动脉闭塞 40 分钟后诱发局部缺血,随后进行 2 小时再灌注(IC)。再灌注开始时给予 cariporide (C, 10 μM)、C 加 5-羟癸酸(5-HD,100 μM,选择性 mitoK(ATP) 通道抑制剂)、C 加 chelerythrine(Chele,1 μM,PKC 抑制剂)或 mitoK(ATP) 通道开放剂 diazoxide(Dz,100 μM)。评估梗塞面积(IS)和心肌功能。通过测量无 C、C + 5-HD 和 Dz 时分离线粒体的光散射减少(LSD,a.u.)来确定钙诱导的通透性转换孔(mPTP)开放。IS 为 IC 中风险区域的 33 ± 2%,C 显著降低 IS(15 ± 2%,p < 0.05),还改善了心肌功能[LVDP = 58 ± 5%(IC)与 80 ± 5%(C)],并减轻了 LSD [0.80 ± 0.04(IC)与 0.51 ± 0.04(C)a.u.]。5-HD 和 Chele 均可消除 C 对 IS 的心脏保护作用。Dz 处理降低 IS 和 LSD 的程度与 C 相似(分别为 15 ± 4%和 0.52 ± 0.04 a.u.)。本研究数据表明,PKC 介导的 mitoK(ATP) 通道激活后 mPTP 开放的衰减是 cariporide 心脏保护作用的关键步骤。